The research aims to evaluate the effects of GLP-1 receptor agonist therapy combined with lifestyle interventions on body composition and metabolic risk in adolescents with obesity.
Analyzed body composition changes in adolescents with obesity
Assessments focused on metabolic syndrome components
Participants showed significant improvements in body composition metrics.
Notable reductions in metabolic syndrome components were observed.
Improved health outcomes suggest effective obesity management strategies.
Abstract
Adolescents with obesity under GLP-1 RA therapy combined with lifestyle intervention demonstrated improvements in body composition and MetS components.